\-\ Texto\\:\\ \ \(0\)\
\-\ noncontributory\\.\ \(24\)\
\-\ surgical\\ resection\\.\\ curettage\\ carries\\ a\\ greater\\ rate\\ of\\ recurrence\\.\ \(0\)\
\-\ 1\\)\\ ap\\ pelvis\\:\\ non\\-aggressive\\ lytic\\ lesion\\ with\\ a\\ sclerotic\\ rim\\ in\\ the\\ left\\ greater\\ trochanter\\,\\ an\\ epiphyseal\\ equivalent\\,\\ which\\ is\\ matrix\\-containing\\.\ \(0\)\
\-\ 2\\)\\ ct\\ left\\ proximal\\ femur\\:\\ chondroid\\ matrix\\ within\\ left\\ greater\\ trochanteric\\ bone\\ lesion\\.\\ mild\\ irregularity\\ of\\ the\\ anterior\\ greater\\ trochanteric\\ cortex\\.\\ \ \(0\)\
\-\ 3\\)\\ mri\\ hip\\(s\\)\\:\\ t1\\ hypointense\\,\\ t2\\ heterogeneous\\ \\ mostly\\ hypointense\\*\\ geographic\\ left\\ greater\\ trochanteric\\ bone\\ lesion\\.\\ \\(\\*likely\\ secondary\\ to\\ high\\ cellularity\\)\\.\ \(0\)\
\-\ clear\\ cell\\ chondrosarcoma\ \(5\)\
\-\ chondroid\\ bone\\ lesions\\ in\\ epiphyseal\\ equivalents\\:\ \(0\)\
\-\ 1\\)\\ chondroblastoma\ \(0\)\
\-\ 2\\)\\ giant\\ cell\\ tumor\ \(0\)\
\-\ 3\\)\\ clear\\ cell\\ chondrosarcoma\ \(0\)\
\-\ 4\\)\\ consider\\ osteoblastoma\ \(0\)\
\-\ 5\\)\\ infection\ \(0\)\
\-\ 6\\)\\ langerhans\\ cell\\ histiocytosis\ \(0\)\
\-\ 7\\)\\ metastases\ \(0\)\
\-\ 45\\ year\\ old\\ man\\ with\\ left\\ hip\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trochanteric\\:\\ 0\\.13884532545378206\ \(0\)\
\-\ greater\\:\\ 0\\.11222784467379375\ \(0\)\
\-\ chondroid\\:\\ 0\\.08139561049527982\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.0752661709018371\ \(0\)\
\-\ \\*\\:\\ 0\\.06650455123664446\ \(0\)\
\-\ cell\\:\\ 0\\.06456617375053109\ \(0\)\
\-\ matrix\\-containing\\:\\ 0\\.06164698198577971\ \(0\)\
\-\ equivalents\\:\\ 0\\.06164698198577971\ \(0\)\
\-\ \\)\\:\\ 0\\.05987728884866896\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.059751379604146775\ \(0\)\
\-\ hypointense\\:\\ 0\\.05669013271564674\ \(0\)\
\-\ hip\\:\\ 0\\.04760660660295746\ \(0\)\
\-\ cellularity\\:\\ 0\\.04554498832847869\ \(0\)\
\-\ trochanter\\:\\ 0\\.04487848357460229\ \(0\)\
\-\ bone\\:\\ 0\\.044547580729927344\ \(0\)\
\-\ clear\\:\\ 0\\.044189183400652386\ \(0\)\
\-\ equivalent\\:\\ 0\\.04319203562483384\ \(0\)\
\-\ carries\\:\\ 0\\.042709567992057954\ \(0\)\
\-\ chondroblastoma\\:\\ 0\\.04225824966242459\ \(0\)\
\-\ geographic\\:\\ 0\\.04105649961398642\ \(0\)\
\-\ non\\-aggressive\\:\\ 0\\.03942282932600386\ \(0\)\
\-\ osteoblastoma\\:\\ 0\\.039137360832855225\ \(0\)\
\-\ curettage\\:\\ 0\\.03719588015734278\ \(0\)\
\-\ lesion\\:\\ 0\\.03651514460140814\ \(0\)\
\-\ langerhans\\:\\ 0\\.03534488327463591\ \(0\)\
\-\ mostly\\:\\ 0\\.03487326592641541\ \(0\)\
\-\ left\\:\\ 0\\.03343025417038164\ \(0\)\
\-\ matrix\\:\\ 0\\.03337389619672691\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.03325227561832223\ \(0\)\
\-\ consider\\:\\ 0\\.03245546261588014\ \(0\)\
\-\ irregularity\\:\\ 0\\.0319372250483716\ \(0\)\
\-\ \\:\\:\\ 0\\.03161607876896965\ \(0\)\
\-\ giant\\:\\ 0\\.028776489917301272\ \(0\)\
\-\ noncontributory\\:\\ 0\\.028650486382317507\ \(0\)\
\-\ 1\\:\\ 0\\.02843813102041548\ \(0\)\
\-\ 3\\:\\ 0\\.027985671702189366\ \(0\)\
\-\ 45\\:\\ 0\\.02760827953504137\ \(0\)\
\-\ lytic\\:\\ 0\\.026748852008306026\ \(0\)\
\-\ sclerotic\\:\\ 0\\.026748852008306026\ \(0\)\
\-\ recurrence\\:\\ 0\\.0260693852359029\ \(0\)\
\-\ femur\\:\\ 0\\.025815066045896777\ \(0\)\
\-\ 2\\:\\ 0\\.025735727223923723\ \(0\)\
\-\ cortex\\:\\ 0\\.02556967220106272\ \(0\)\
\-\ metastases\\:\\ 0\\.025529597552748143\ \(0\)\
\-\ rim\\:\\ 0\\.025293855893011696\ \(0\)\
\-\ rate\\:\\ 0\\.023291758674656247\ \(0\)\
\-\ 7\\:\\ 0\\.022896887264392114\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.02197339270486018\ \(0\)\
\-\ ap\\:\\ 0\\.021854258528968096\ \(0\)\
\-\ pelvis\\:\\ 0\\.02171392592022118\ \(0\)\
\-\ t1\\:\\ 0\\.018940528225344363\ \(0\)\
\-\ resection\\:\\ 0\\.018635773814826704\ \(0\)\
\-\ proximal\\:\\ 0\\.017940861410538567\ \(0\)\
\-\ 6\\:\\ 0\\.017846994135488632\ \(0\)\
\-\ 5\\:\\ 0\\.01748363931779135\ \(0\)\
\-\ infection\\:\\ 0\\.017370745273236413\ \(0\)\
\-\ s\\:\\ 0\\.01713823543436774\ \(0\)\
\-\ t2\\:\\ 0\\.016913208173079383\ \(0\)\
\-\ likely\\:\\ 0\\.016855174586962632\ \(0\)\
\-\ secondary\\:\\ 0\\.016706503262299353\ \(0\)\
\-\ 4\\:\\ 0\\.016650153183070247\ \(0\)\
\-\ high\\:\\ 0\\.01635346895857913\ \(0\)\
\-\ lesions\\:\\ 0\\.015996926617789845\ \(0\)\
\-\ mild\\:\\ 0\\.01573603813937858\ \(0\)\
\-\ anterior\\:\\ 0\\.01539015960673243\ \(0\)\
\-\ man\\:\\ 0\\.014132390511118875\ \(0\)\
\-\ tumor\\:\\ 0\\.01393169441685882\ \(0\)\
\-\ mri\\:\\ 0\\.013729201782619719\ \(0\)\
\-\ surgical\\:\\ 0\\.012560991400359815\ \(0\)\
\-\ within\\:\\ 0\\.011399520338364206\ \(0\)\
\-\ which\\:\\ 0\\.011154857253444396\ \(0\)\
\-\ \\(\\:\\ 0\\.01010296120620784\ \(0\)\
\-\ ct\\:\\ 0\\.008358766806937363\ \(0\)\
\-\ an\\:\\ 0\\.008263390659333776\ \(0\)\
\-\ pain\\:\\ 0\\.007297959213501641\ \(0\)\
\-\ year\\:\\ 0\\.006686050834076327\ \(0\)\
\-\ old\\:\\ 0\\.0061184237542815005\ \(0\)\
\-\ in\\:\\ 0\\.00589366755440916\ \(0\)\
\-\ \\,\\:\\ 0\\.005679232143719316\ \(0\)\
\-\ a\\:\\ 0\\.0055468503750853325\ \(0\)\
\-\ is\\:\\ 0\\.0039321033453477315\ \(0\)\
\-\ to\\:\\ 0\\.0029864902688320717\ \(0\)\
\-\ \\.\\:\\ 0\\.00223423653759522\ \(0\)\
\-\ the\\:\\ 0\\.0019335564294213398\ \(0\)\
\-\ with\\:\\ 0\\.001636422043215241\ \(0\)\
\-\ of\\:\\ 0\\.0016294237873844535\ \(0\)\
